Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

Intercept Pharmaceuticals Plans Changes to Its Fatty Liver Disease Study

INVESTING

By Laura Garcell Nimylowycz
Sep 1, 2020 2:42 PM EDT

PRESS RELEASES

By GlobeNewswire
Jan 27, 2021 1:35 PM EST

PRESS RELEASES

By GlobeNewswire
Jan 5, 2021 8:00 AM EST

PRESS RELEASES

By PR Newswire
Jan 4, 2021 9:47 AM EST

PRESS RELEASES

By PR Newswire
Jan 4, 2021 8:30 AM EST

PRESS RELEASES

By Business Wire
Jan 3, 2021 11:00 AM EST

PRESS RELEASES

By PR Newswire
Jan 2, 2021 11:20 PM EST

PRESS RELEASES

By Business Wire
Jan 1, 2021 9:00 PM EST

PRESS RELEASES

By Business Wire
Dec 30, 2020 10:00 AM EST

PRESS RELEASES

By Business Wire
Dec 28, 2020 9:00 PM EST

PRESS RELEASES

By PR Newswire
Dec 22, 2020 12:47 PM EST

PRESS RELEASES

By PR Newswire
Dec 10, 2020 9:47 AM EST

PRESS RELEASES

By GlobeNewswire
Dec 10, 2020 8:00 AM EST

PRESS RELEASES

By PR Newswire
Dec 7, 2020 11:46 PM EST

PRESS RELEASES

By Business Wire
Dec 5, 2020 2:45 PM EST

PRESS RELEASES

By PR Newswire
Dec 3, 2020 4:05 AM EST

PRESS RELEASES

By PR Newswire
Nov 24, 2020 7:28 PM EST

PRESS RELEASES

By GlobeNewswire
Nov 24, 2020 7:00 AM EST

PRESS RELEASES

By Business Wire
Nov 20, 2020 4:42 PM EST

PRESS RELEASES

By PR Newswire
Nov 20, 2020 12:30 PM EST

PRESS RELEASES

By PR Newswire
Nov 18, 2020 11:30 AM EST

PRESS RELEASES

By Business Wire
Nov 17, 2020 11:00 AM EST

PRESS RELEASES

By GlobeNewswire
Nov 16, 2020 8:00 AM EST

PRESS RELEASES

By PR Newswire
Nov 14, 2020 2:50 PM EST

PRESS RELEASES

By Business Wire
Nov 13, 2020 12:00 PM EST

Trade with Jim Cramer 14 Days Free

LATEST NEWS

Intercept Pharmaceuticals to Reduce Its Workforce by 25%

Intercept Company Statement On Analyst Note

Intercept To Present At The 39th Annual J.P. Morgan Healthcare Conference

ICPT INVESTOR DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors Of The Deadline To File A Lead Plaintiff Motion In A Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

DEADLINE TODAY: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

ICPT Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Intercept Pharmaceuticals, Inc. Shareholders Of Class Action And Lead Plaintiff Deadline: January 4, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Intercept Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - ICPT

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That A Class Action Lawsuit Has Been Filed Against Intercept Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm

The Law Offices Of Frank R. Cruz Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That A Class Action Lawsuit Has Been Filed Against Intercept Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm

ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors Of Important January 4 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - ICPT

ICPT INVESTOR DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors Of The Deadline To File A Lead Plaintiff Motion In A Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Leadership Transition

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - ICPT

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - ICPT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Intercept Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - ICPT

ROSEN, A LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors Of Important January 4 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact Firm - ICPT

Intercept To Present At The Piper Sandler 32nd Annual Virtual Healthcare Conference

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact Firm - ICPT

Glancy Prongay & Murray LLP Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)

The Law Offices Of Frank R. Cruz Announces The Filing Of A Securities Class Action On Behalf Of Intercept Pharmaceuticals, Inc. (ICPT) Investors

ICPT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Intercept Pharmaceuticals, Inc. Shareholders Of Class Action And Lead Plaintiff Deadline: January 4, 2021

New Data From The Interim Analysis Of REGENERATE Show OCA Improved Noninvasive Measures Of Fibrosis In A Subgroup Of High-Risk Patients With Fibrosis Due To NASH

ROSEN, RESPECTED INVESTOR COUNSEL, Announces Filing Of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.; Encourages Investors With Losses In Excess Of $100K To Contact Firm - ICPT

Deadline Reminder: Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)